EPO Patents = 1

Trademarks = 1

Forward Citations = 0

Loading Chart...

13 inventors (with patents filed for the assignee):

Douglas J Jolly (5 out of 53 patents)

Amy Lin (3 out of 16 patents)

Harry E Gruber (3 out of 47 patents)

4. Derek G Ostertag (2 out of 4 patents)

5. Andrew Hofacre (1 out of 1 patent)

6. Daniel J Hogan (1 out of 5 patents)

7. Joan M Robbins (1 out of 4 patents)

8. Kay Olmstead (1 out of 16 patents)

9. Noriyuki Kasahara (1 out of 21 patents)

10. Christopher R Logg (1 out of 14 patents)

11. Wen Luo (1 out of 5 patents)

12. Hong Sun (1 out of 1 patent)

13. Carlos E Ibanez (1 out of 8 patents)

6 patents: Sort by Forward Citations

1. 11421280 - Methods and composition for the prediction of the activity of enzastaurin (2022-08-23),

2. 11279949 - Recombinant vectors comprising 2A peptide (2022-03-22),

3. 11230719 - Retroviral vector having immune-stimulating activity (2022-01-25),

4. 11191764 - Formulations of 5-fluorocytosine and uses thereof (2021-12-07),

5. 11065311 - Retroviral vector with mini-promoter cassette (2021-07-20),

6. 11060112 - Producer cells for replication competent retroviral vectors (2021-07-13),

Denovo Biopharma is a biotechnology company focused on developing innovative treatments for cancer and other serious diseases. Our unique approach combines sophisticated data analytics with cutting-edge biology to identify novel drug targets and bring new therapies to market. With a team of experienced scientists and industry experts, we are committed to making a significant impact on the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

6 Patents

#734 in San Diego, CA

#10,291 in California

#43,794 in US

San Diego, CA, United States of America

Denovo Biopharma LLC